Karnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive ...

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded. (Operator Instructions) I'd now like to hand the call over ...

Oxford BioTherapeutics (OBT), a clinical-stage oncology firm, has announced a long-term partnership with Roche ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...

Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...

The works shows that white blood cells called neutrophils form gooey, protein-rich rings around sites where the skin has been ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...

Here are a few things to think about. Alecensa (alectinib) is a medicine used for treating certain lung cancers. Alecensa is used to treat non-small-cell lung cancer (NSCLC) that is anaplastic ...